Statistics for Sartorius Stedim Biotech (id:10585 DIM)
Valuation metrics
Market cap
16.40B
Enterprise value
18.92B
Trailing P/E (ttm)
100.36
Forward P/E
39.12
PEG ratio
39.12
Price/Sales (ttm)
6.00
Price/Book (mrq)
4.24
Enterprise Value/Revenue
6.92
Enterprise Value/EBITDA
29.30
Overview
Shares outstanding
97.29M
Float
29.70M
Shares short
% Held by insiders
0.70%
% Held by institutions
0.12%
Average volume (10 days)
64.83K
Average volume (90 days)
Price summary
52-Week low
139.10
52-Week high
281.00
52-Week change
-12.84%
Beta
0.67
50-Day moving average
184.30
200-Day moving average
199.09
Dividends and splits
Forward annual dividend rate
2.76
Forward annual dividend yield
0.02
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
0.50
Payout ratio
0.41
Dividend date
Ex-dividend date
April 02th, 2024
Last split factor
2:1
Last split date
May 06th, 2016
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
5.87%
Operating margin
10.79%
Operational effectiveness
Return on assets
3.12%
Return on equity
5.02%
Income statement
Revenue (ttm)
28.66
Revenue per share (ttm)
28.66
Quarterly revenue growth (yoy)
-0.01
Gross profit (ttm)
1.23B
EBITDA
579.50M
Net income to common (ttm)
160.60M
Diluted EPS (ttm)
1.68
Quarterly earnings growth (yoy)
-0.80%
Balance sheet
Total cash (mrq)
482.60M
Total cash per share (mrq)
4.92
Total debt (mrq)
2.83B
Total Debt/Equity (mrq)
71.89
Current ratio (mrq)
213.80%
Book value per share (mrq)
39.78
Cash flow
Cash flow statement
866.30M
Levered free cash flow (LFCF)
221.75M